Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Researchers at the Eye Clinic of the University Hospital Bonn (UKB) and the University of Bonn have found a promising imaging monitoring method utilizing optical coherence tomography angiography (OCTA). The technique assesses blood flow in retinal vessels, revealing crucial insights…

Researchers at the University of Oklahoma Health Sciences and Memorial Sloan Kettering (MSK) Cancer Center have unveiled a novel approach to treating diabetic retinopathy that could potentially transform outcomes for patients at risk of blindness. Anti-Ceramide Immunotherapy: A Novel Treatment…

COVID-19, a global pandemic caused by the SARS-CoV-2 virus, has affected nearly every aspect of healthcare, including eye care services. Since the virus was first identified in December 2019, it has caused significant disruptions in healthcare systems worldwide. This article…

A group of researchers from the University of California, Irvine, has made a significant discovery: an exceptional antibody that could pave the way for treating Retinitis Pigmentosa. This condition results in the deterioration of central vision, as well as night…

Micro Labs, based in Bengaluru, announced the launch of Trisopt, the world’s first fixed-dose combination (FDC) to include Brimonidine, Timolol, and Brinzolamide in an ophthalmic suspension, designed specifically for the management of glaucoma. The drug is manufactured within Micro Labs’…

Early Retinal Imaging: The Beginnings of Ophthalmic Photography Early retinal imaging — The origins of (retinal) ophthalmic photography go back around 150 years when Drs Jackman and Webster, in the USA, published the first robust account of capturing images of…

In a retrospective study conducted by Brazilian investigators, concerns about the occurrence of ocular metastases were addressed. Led by first author Matheus Senna Pereira Ogata, MD, from the Department of Ophthalmology and Visual Sciences at the Paulista Medical School, Federal…

In our daily lives, we usually take our eyesight for granted and avoid going to see a professional regularly. Our eyesight is one of the most valuable assets that we have. There are hundreds of different eye diseases and conditions.…

A recent study led by investigators from Mass Eye and Ear has found a concerning association between the use of semaglutide, prescribed for diabetes and weight loss under brand names Ozempic and Wegovy, developed by Novo Nordisk, and an increased…

In a groundbreaking development for diabetes management, the LENS trial has revealed that fenofibrate, a medication typically used to lower cholesterol, can significantly reduce the risk of diabetic retinopathy progression by 27%. These findings were presented at the American Diabetes…